TrialClinical and translational science2025

First-In-Human Safety, Tolerability, and Pharmacokinetics of PPI-1011, a Synthetic Plasmalogen Precursor.

Tara Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.